At ENTA, we’re constantly monitoring and adjusting our protocols to make sure we are safely and effectively providing the care you need. For more information on how ENTA is taking extra precautions to provide the safest environment possible during the COVID-19 pandemic, please click here.
05/19/2011 in press release
Tarrytown, NY – April 28, 2011. ENT and Allergy Associates, LLP (ENTA) today announced a significant expansion of its growing presence on Long Island, through a merger with Suffolk County based Peconic Ear, Nose, Throat & Facial Plastic Surgery P.C. The merger becomes effective on July 1st, 2011.
The result will be a brand new ENTA office at 292 Shade Tree Lane in Aquebogue, NY, a second location at 300 Pantigo Place in East Hampton, NY and a third location at 365 County Road 39-A in Southampton, NY. These three offices will serve both the residents of New York’s East End as well as those current ENTA patients who vacation in the Hamptons. In addition, these new offices will complement ENTA’s current Long Island locations, in Nassau County’s Garden City and Lake Success, bringing the Practice's overall total to over 125 physicians across 38 clinical office locations.
Five physicians from Peconic ENT will join ENTA — otolaryngologists Drs. Kevin Braat, Paul J. Davey, Paul E. Kelly, Eric T. Scarbrough and Allergist and Immunologist, Erin Elizabeth McGintee.
Dr. Kevin Braat is a native Long Islander who has been living and practicing on the East End since 2000. He is a past Medical Staff President and member of the Board of Trustees of Peconic Bay Medical Center as well as a past Physician of the Year at Peconic Bay Medical Center.
Dr. Braat is also affiliated with Southampton Hospital, Eastern Long Island Hospital and the Suffolk Surgery Center. He trained at the prestigious University of Pennsylvania Medical School, with additional pediatric training at the Children’s Hospital of Philadelphia. Dr. Braat’s further post-graduate training was in the diagnosis and treatment of allergic disorders. He practices general otolaryngology (ear, nose & throat) with a special interest in Pediatric Otolaryngology, Sinus/Allergy conditions and Head & Neck Surgery. He is also a board member of the East End Health Alliance Physician-Hospital Organization.
Dr. Paul J. Davey, a Board Certified Otolaryngologist (ENT specialist) with advance training in the diagnosis and treatment of allergic and sinus disorders, also has vast experience and expertise in the diagnosis and treatment of benign and malignant tumors of the head and neck.
Dr. Davey has been practicing on the East End of Long Island since 1995, following a commission as Chief of Otolaryngology in the US Army. His current hospital affiliations are with Southampton Hospital and Peconic Bay Medical Center in Riverhead. Dr. Davey practices general otolaryngology (ear, nose & throat) with a special interest in Pediatric Otolaryngology, Sinus/Allergy conditions and Head & Neck Surgery.
Dr. Eric T. Scarbrough, a Board certified Otolaryngologist with training received at top medical institutions, believes in a team oriented approach to health care, where specialists and primary care doctors work together with patients to formulate the best treatment plan for the individual. Dr. Scarbrough practices general ENT, with specific interests in pediatrics, sinus and nasal diseases, and
Dr. Paul E. Kelly has been making a difference in peoples lives for the over 18 years, performing Surgical Procedures, Injectable Fillers and Botox, and dispensing Skin Care Products. He helps his patients put their best face forward with confidence and well being.
His training and Board Certifications are in both Facial Plastic and Reconstructive Surgery and Otolaryngology Head and Neck Surgery, and listens intently to the whole person and educates each patient to guide them in selecting their best personalized course of action
Dr. Erin Elizabeth McGintee is a native of East Hampton, obtaining her medical degree at the State University of New York at Stony Brook, (where she was a member of the AOA Medical Honor Society). She received her pediatric training at the Children’s Hospital of Philadelphia, and following residency Dr. McGintee pursued a three-year fellowship in allergy and immunology at the Children’s Hospital of Philadelphia, with adult cross training at the Hospital of the University of Pennsylvania. She is board certified in both pediatrics and allergy and immunology, Dr. McGintee practices both adult and pediatric allergy and clinical immunology, with specific interests including asthma, atopic dermatitis, food allergy, and allergic rhinoconjunctivitis/sinusitis.
Wayne Eisman, MD, President of ENTA, commented “ENT & Allergy Associates is truly looking forward to our merger with Peconic ENT, and is fully confident that these superb physicians will allow our Practice to offer the highest level of care to both year round residents of Eastern Long Island as well as those who visit the Hamptons on holiday. We couldn’t be more delighted”.
Added Kevin Braat , MD, Managing Partner of Peconic ENT, “This joinder will allow us to provide our patients with the enormous benefits of multi sub-specialty care, close connections to the Mt Sinai Medical Center and the American Cancer Society, and a state-of-the-art EMR system&hellip,and it will allow us to focus more of our time on patient care”.
ENT and Allergy Associates, LLP is the largest and most comprehensive ear, nose, throat, allergy and audiology practice in the nation with 38 offices and over 125 physicians. Each location provides a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, and Hearing Aid dispensing. Visit www.entandallergy.com for more information. The practice has a clinical alliance with the Mount Sinai Medical Center for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.